The impact of homologous recombination deficiency on the prognosis of epithelial ovarian cancer

Haiqi Su; Yinan Wang; Xiaopei Chao; Huanwen Wu; Yan You; Shuru Zhao; Feiyue Wang; Bao Sun; Zhen Zhang; Ming Wu; Zicheng Zhao; Lei Li

doi:10.1002/ctm2.70143

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (1) : e70143 DOI: 10.1002/ctm2.70143

LETTER TO THE JOURNAL

The impact of homologous recombination deficiency on the prognosis of epithelial ovarian cancer

Haiqi Su ¹^,²^,³
, Yinan Wang ⁴^,⁵
, Xiaopei Chao ¹^,²^,³
, Huanwen Wu ⁶
, Yan You ⁶
, Shuru Zhao ⁷
, Feiyue Wang ⁷
, Bao Sun ⁸
, Zhen Zhang ⁸
, Ming Wu ¹^,^†
, Zicheng Zhao ⁷^,^†
, Lei Li ¹^,²^,³^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Haiqi Su,Yinan Wang,Xiaopei Chao,Huanwen Wu,Yan You,Shuru Zhao,Feiyue Wang,Bao Sun,Zhen Zhang,Ming Wu,Zicheng Zhao,Lei Li. The impact of homologous recombination deficiency on the prognosis of epithelial ovarian cancer. Clinical and Translational Medicine, 2025, 15(1): e70143 DOI:10.1002/ctm2.70143

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.